The politics of comparative effectiveness research: Lessons from recent history

Journal of Health Politics, Policy and Law

Volumn 39, Issue 1, 2014, Pages 139-170

  Sorenson, Corinna ^a   Gusmano, Michael K ^b   Oliver, Adam ^a,c  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^b HASTINGS CENTER   (United States)

^c KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; COMPARATIVE EFFECTIVENESS; COST BENEFIT ANALYSIS; GOVERNMENT; HEALTH CARE POLICY; HUMAN; LEGAL ASPECT; MEDICAID; MEDICARE; ORGANIZATION AND MANAGEMENT; POLITICS; UNITED STATES;

COMPARATIVE EFFECTIVENESS RESEARCH; COST-BENEFIT ANALYSIS; HEALTH CARE REFORM; HEALTH POLICY; HUMANS; MEDICAID; MEDICARE; POLITICS; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UNITED STATES; UNITED STATES AGENCY FOR HEALTHCARE RESEARCH AND QUALITY; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 84894297357     PISSN: 03616878     EISSN: 15271927     Source Type: Journal    
DOI: 10.1215/03616878-2395199     Document Type: Article

References (67)

1. AHRQ (Agency for Healthcare Research and Quality). 1999. The Outcome of Outcomes Research at AHCPR: Final Report. AHCPR Publication No. 99-RO44. Rockville, MD: AHRQ.
2. Appleby, J. 2008. "The Case of CTAngiography: How Americans View and Embrace New Technology." Health Affairs 27, no. 6: 1515-21.
3. Avorn, J. 2009. "Debate about Funding Comparative-Effectiveness Research." New England Journal of Medicine 360, no. 19: 1927-29.
4. Avorn, J., and M. Fisher. 2010. "'Bench to Behavior': Translating Comparative Research into Improved Clinical Practice." Health Affairs 29, no. 10: 1891-99.
5. Balas, E. A., and S. A Boren. 2000. "Managing Clinical Knowledge for Health Care Improvement." In Yearbook of Medical Informatics. Bethesda, MD: National Library of Medicine.
6. Basu, A., and T. J. Philipson. 2010. The Impact of Comparative Effectiveness Research on Health and Health Spending. NBER Working Paper No. 15633. Cambridge, MA: National Bureau of Economic Research.
7. Bimber, B. 1996. The Politics of Expertise in Congress: The Rise and Fall of the Office of Technology Assessment. Albany: State University of New York Press.
8. Blumenthal, D. 1983. "Federal Policy toward Health Care Technology: The Case of the National Center." Milbank Quarterly 61, no. 4: 584-612.
9. Blumstein, J. F. 1997. "The Oregon Experiment: The Role of Cost-Benefit Analysis in the Allocation of Medicaid Funds." Social Science and Medicine 45, no. 4: 545-54.
10. Boyle, J. F. 1981. "NCHCT Could Impede Health Care Advancement and Delivery." Medical Instrumentation 15, no. 5: 296-98.
11. Brown, L. 1991. "The National Politics of Oregon's Rationing Plan." Health Affairs 10, no. 2: 28-51.
12. Carman, K. L., M. Maurer, J.M. Yegian, J. McGee, M. Evers, and K. O. Marlo. 2010. "Evidence That Consumers Are Skeptical about Evidence-Based Health Care." Health Affairs 29, no. 7: 1400-1406.
13. CBO (Congressional Budget Office). 2007. Research on the Comparative Effectiveness of Medical Treatments: Issues and Options for an Expanded Federal Role. Washington, DC: CBO.
14. CMS (Centers for Medicare and Medicaid Services). 1999. "Procedures for Making National Coverage Decisions." Federal Register 64, no. 22 (April 27).
15. CMS (Centers for Medicare and Medicaid Services). 2000. "Criteria for Making National Coverage Decisions." Federal Register 65, no. 95 (May 16).
16. Conservatives for Patients' Rights. 2009. "Conservatives for Patients' Rights Launches Multi-Million Dollar Campaign Promoting Free-Market Health Reform Solutions." Press release, March 3, Conservatives for Patients' Rights.
17. Cotter, D. 2009. "The National Center for Health Technology: Lessons Learned." Health Affairs (blog), January 22. http://healthaffairs.org/blog/2009/01/22/the -national-center-for-health-care-technology-lessons-learned/.
18. CRS (Congressional Research Service). 2007. Comparative Clinical Effectiveness and Cost-Effectiveness: Background, History, and Overview. Washington, DC: CRS.
19. Eddy, D. M. 1991. "Oregon's Methods: Did Cost-Effectiveness Analysis Fail?" Journal of the American Medical Association 266, no. 15: 2135-41.
20. Eisenberg, J., and D. Zarin. 2002. "Health Technology Assessment in the United States: Past, Present, and Future." International Journal of Technology Assessment in Health Care, 18, no. 2: 192-98.
21. Foote, S. B. 2002. "Why Medicare Cannot Promulgate a National Coverage Rule: A Case of Regula Mortis." Journal of Health Politics, Policy and Law 2, no. 5: 707-30.
22. Fredrick, J. 2008. "One Sure Election Outcome: Change in Healthcare System." Drug Store News, August 18: 68.
23. GAO (General Accounting Office). 1995. Practice Guidelines: Overview of Agency for Health Care Policy and Research Efforts. Washington, DC: GAO.
24. Gerber, A. S., and E. M. Patashnik. 2010. "Problem Solving in a Polarized Age: Comparative Effectiveness and the Politicization of Evidence-Based Medicine." Forum, manuscript 1353: 1-13.
25. Gerber, A. S., E. M. Patashnik, D. Doherty, and C. Dowling. 2010. "The PublicWants Information, Not Broad Mandates, from Comparative Effectiveness Research." Health Affairs 29, no. 10: 1872-81.
26. Gray, B. H., M. K. Gusmano, and S. Collins. 2003. "AHCPR and the Changing Politics of Health Services Research." Health Affairs (Web Exclusive), June 25. doi: 10.1377/hlthaff.w3.283.
27. Gusmano, M. K., and B. H. Gray. 2010. "Evidence and Fear: Navigating the Politics of Evidence Based Medicine." AcademyHealth Reports, June. www.academyhealth .org/files/publications/academyhealthreports/evidenceandfear.pdf.
28. HCFA (Health Care Financing Administration). 1989. "Medicare Program: Criteria and Procedures for Making Medical Services Coverage Decisions That Relate to Health Care Technology." Federal Register 54, no. 30 ( January 30).
29. Healy, P., and C. Dean. 2007. "Clinton Says She Would Shield Science from Politics." New York Times, October 5.
30. Iglehart, J. K. 2010. "The Political Fight over Comparative Effectiveness Research." Health Affairs 29, no. 10: 1757-60.
31. IOM (Institute of Medicine). 2007. Learning What Works Best: The Nation's Need for Evidence on Comparative Effectiveness in Health Care. IOM Roundtable on Evidence-Based Medicine. Washington, DC: Institute of Medicine.
32. Kaiser Family Foundation. 2012. "Employee Health Benefits 2012 Annual Survey." September 11. ehbs.kff.org/.
33. Keenan, P. S., P. J. Neumann, and K. A. Phillips. 2006. "Biotechnology and Medicare's New Technology Policy: Lessons from Three Case Studies." Health Affairs 25, no. 5: 260-69.
34. Kunkle, G. C. 1995. "New Challenge or the Past Revisited? The Office of Technology Assessment in Historical Context." Technology in Society 17, no. 2: 175-96.
35. Kupersmith, J. 2009. "What Can the Health Care System Learn from Thirty Years of Comparative Effectiveness Research in the VA?" Paper presented at the Department of Veterans Affairs Symposium, Washington, DC, October 22.
36. Luce, B. R., and R. S. Cohen. 2009. "Health Technology Assessment in the United States." International Journal of Technology Assessment in Health Care 25, suppl. 1: 33-41.
37. Luce, B. R., M. Drummond, B. Jonsson, P. J. Neumann, J. S. Schwartz, U. Siebert, and S. D. Sullivan. 2010. "EBM, HTA, and CER: Clearing the Confusion." Milbank Quarterly 88, no. 2: 256-76.
38. Maio, V., and J. J. Gagne. 2010. "Impact of ALLHAT Publication on Antihypertensive Prescribing Patterns in Regione Emilia-Romagna, Italy." Journal of Clinical Pharmaceutical Therapy 35: 55-61.
39. Malakoff, D. 2001. "Memo to Congress: Get Better Advice." Science 292, no. 5525: 2229-30.
40. McGlynn, E. A., and R. H. Brook. 2001. "Keeping Quality on the Policy Agenda." Health Affairs 20, no. 3: 82-90.
41. Medpac. 2008. Report to Congress: Reforming the Delivery System.Washington, DC: Medpac.
42. Neumann, P. J. 2006. "Emerging Lessons from the Drug Effectiveness Review Project." Health Affairs 24: 80-92.
43. Neumann, P. J. 2010. "Legislating against Use of Cost-Effectiveness Information." New England Journal of Medicine 363, no. 16: 1495-97.
44. Neumann, P. J., N. Nivi, M. T. Beinfeld, B. Levine, P. S. Keenan, E. K. Halpern, and G. S. Gazelle. 2005. "Medicare's National Coverage Decisions, 1999-2003: Quality of Evidence and Review Times." Health Affairs 24, no. 1: 243-54.
45. Neumann, P. J., A. B. Rosen, and M. C. Weinstein. 2005. "Medicare and Cost- Effectiveness Analysis." New England Journal of Medicine 353, no. 14: 1516-22.
46. Obama-Biden Presidential Campaign. 2008. "Barack Obama and Joe Biden's Plan to Lower Health Care Costs and Ensure Affordable, Accessible Health Care Coverage for All." Campaign Document, October 3. Washington, DC: Obama-Biden Presidential Campaign.
47. Oberlander, Jonathan. 2007. "Health ReformInterrupted: The Unraveling of theOregon Health Plan." Health Affairs 26, no. 1: w96-w105. doi:10.1377/hlthaff.26.1.w96.
48. Oberlander, J., T. Marmor, and L. Jacobs. 2001. "Rationing Medical Care: Rhetoric and Reality in the Oregon Health Plan." Canadian Medical Association Journal 164, no. 1: 1583-87.
49. Oliver, A. 2007. "The Veterans Health Administration: An American Success Story?" Milbank Quarterly 85, no. 1: 5-35.
50. OTA (Office of Technology Assessment). 1994. Identifying Health Technologies That Work: Searching for Evidence. Washington, DC: OTA.
51. OTA (Office of Technology Assessment). 1995. Health Care Technology and Its Assessment in Eight Countries. OTA-BP-H-140. Washington, DC: OTA.
52. Patel, K. 2010. "Health Reform's Tortuous Route to the Patient-Centered Outcomes Research Institute." Health Affairs 29, no. 10: 1777-82.
53. Pear, R. 1991. "Medicare to Weigh Cost as a Factor for Reimbursement." New York Times, April 21.
54. Pearson, S. D., and P. B. Bach. 2010. "How Medicare Could Use Comparative Effectiveness Research in Deciding on New Coverage and Reimbursement." Health Affairs 29, no. 10: 1796-1804.
55. PPRC (Physician Payment Review Commission). 1995. Annual Report to Congress. Washington, DC: PPRC.
56. Redberg, R. F., and J. Walsh. 2008. "Pay Now, Benefits May Follow: The Case of Cardiac Computed Tomographic Angiography." New England Journal of Medicine 359, no. 22: 2309-11.
57. Robinson, J. C. 2010. "Comparative Effectiveness Research: From Clinical Information to Economic Incentives." Health Affairs 29, no. 10: 1788-95.
58. Schoen, C., S. Guterman, A. Shih, J. Lau, S. Kasimow, A. Gauthier, and K. Davis. 2007. Bending the Curve: Options for Achieving Savings and Improving Value in U.S. Health Spending. New York: Commonwealth Fund.
59. Steinberg, E. P., and B. Luce. 2005. "Evidence Based? Caveat Emptor!" Health Affairs 24: 80-92.
60. Sullivan, S. D., J. Watkins, B. Sweet, and S. D. Ramsey. 2009. "Health Technology Assessment in Health-Care Decisions in the United States." Value in Health 12, suppl. 2: S39-S44.
61. Tunis, S. R., and H. Gelband. 1994. "Health Care Technology in the United States." Health Policy 30: 335-96.
62. Tunis, S. R., and S. D. Pearson. 2006. "Coverage Options for Promising Technologies: Medicare's 'Coverage with Evidence Development.' " Health Affairs 25, no. 5: 1218-30.
63. US Senate Committee on HELP (Health, Education, Labor, and Pensions). 2009. "Enzi: No Washington Bureaucrat Should Deny or Delay Care for You and Your Family." Press release, June 22. www.help.senate.gov/old_site/Min_press/2009_ 06_22_a.pdf.
64. Wennberg, J. E. 1984. "Dealing with Medical Practice Variations: A Proposal for Action." Health Affairs 3, no. 2: 6-32.
65. Wilensky, G. R. 2006. "Developing a Center for Comparative Effectiveness Information." Health Affairs 25, no. 6: 572-85.
66. Will, G. F. 2009. "How the GOP Should Measure the Stimulus." Washington Post, January 29.
67. Zhang, J. 2009. "Push to Compare Treatments Worries Drug, Device Makers." Wall Street Journal, April 15.